---
category: news
title: "Kiromic Announces Submission of Two IND Applications for PD1 Gamma-delta CAR - T cell Therapy with the FDA"
excerpt: "Kiromic BioPharma (“the Company”) (NASDAQ: KRBP), a target discovery and gene-editing company utilizing artificial intelligence and its proprietary ... PD1 Gamma-delta CAR (PD1-GDT CAR) T cell therapy is a novel method for “off-the-shelf ..."
publishedDateTime: 2020-12-17T18:43:00Z
originalUrl: "https://www.morningstar.com/news/business-wire/20201217005901/kiromic-announces-submission-of-two-ind-applications-for-pd1-gamma-delta-car-t-cell-therapy-with-the-fda"
webUrl: "https://www.morningstar.com/news/business-wire/20201217005901/kiromic-announces-submission-of-two-ind-applications-for-pd1-gamma-delta-car-t-cell-therapy-with-the-fda"
type: article
quality: 1
heat: 1
published: false

provider:
  name: Morningstar%2c Inc.
  domain: morningstar.com

topics:
  - AI in Healthcare
  - AI

secured: "IUomZ67YIlWXX6tHzq7L25+6URWCG8BsRxYdMKOgMdX2+skgnjn0Ds2b54cMDjWXc933aVgXWxr6t/DavNegDYYO5SPVbpCxOv2JQFupahWdG6xc2EkUfn+LKoi+7VuySoKsCZKMdIgZKYzy8bnB/Cnauk00cmmSTUUBqg2+YzrJD8iYGOJYj7qzuApE9Rb3JiEk0p9JiK8kTYMgCZVDy+gCRobdwu7XID4b6Nybe+YsVcEBZVO9nWNHFgeijmYyP4zLBsLr0C5tAjufwqzu0hFL7T7Ft40+s8Lm/97kLdD+jV0itr5k/+BM9Wb/sOUjjiFfyH535calLcm/rL7RMqlNiAEQ0tC2g/RkDsI2LTY=;xj1gM303GDSOPGbnunFWjQ=="
---

